Deals In Depth: February 2012
Pfizer and Zhejiang Hisun Pharmaceutical together invested $545 million to create a Chinese generics joint venture. Dainippon Sumitomo Pharma expanded its cancer pipeline though the acquisition of Boston Biomedical. Driven by a large amount of FOPOs, biopharma financing totaled $1.8 billion in February, while device companies raised $248 million.
You may also be interested in...
Precision Patient Outcomes' compliance costs from settlement with FTC “are not onerous,” says New Civil Liberties Alliance attorney John Vecchione. Settlement requires firm to notify customers and resellers about lawsuit and preserve all scientific evidence for health claims made for its products.
As previously indicated, AbbVie will go with an internal candidate, president and COO Robert Michael, to succeed Rick Gonzalez as CEO. The company has recently positioned Michael prominently.
Intuitive Surgical is facing claims that malfunctions of its da Vinci surgical robot led to a woman’s death following a laparoscopic surgery.